Suppression of the Inflammatory Response in Experimental Arthritis is Mediated Via Estrogen Receptor Alpha but Not Estrogen Receptor Beta

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2010 May 26

PMID 20497523

Citations 14

Authors

John Dulos

Peter Vijn

Cindy van Doorn

Claudia L Hofstra

Desiree Veening-Griffioen

Jan de Graaf

Fred A Dijcks

Annemieke M H Boots

Affiliations

Soon will be listed here.

Abstract

Introduction: The immune modulatory role of estrogens in inflammation is complex. Both pro- and anti-inflammatory effects of estrogens have been described. Estrogens bind both estrogen receptor (ER)alpha and beta. The contribution of ERalpha and ERbeta to ER-mediated immune modulation was studied in delayed type hypersensitivity (DTH) and in experimental arthritis

Methods: ER-mediated suppression of rat adjuvant arthritis (AA) was studied using ethinyl-estradiol (EE) and a selective ERbeta agonist (ERB-79). Arthritis was followed for 2 weeks. Next, effects of ER agonists (ethinyl-estradiol, an ERalpha selective agonist (ERA-63) and a selective ERbeta agonist (ERB-79) on the development of a tetanus toxoid (TT)-specific delayed type hypersensitivity response in wild type (WT) and in ERalpha- or ERbeta-deficient mice were investigated. Finally, EE and ERA-63 were tested for their immune modulating potential in established collagen induced arthritis in DBA/1J mice. Arthritis was followed for three weeks. Joint pathology was examined by histology and radiology. Local synovial cytokine production was analyzed using Luminex technology. Sera were assessed for COMP as a biomarker of cartilage destruction.

Results: EE was found to suppress clinical signs and symptoms in rat AA. The selective ERbeta agonist ERB-79 had no effect on arthritis symptoms in this model. In the TT-specific DTH model, EE and the selective ERalpha agonist ERA-63 suppressed the TT-specific swelling response in WT and ERbetaKO mice but not in ERalphaKO mice. As seen in the AA model, the selective ERbeta agonist ERB-79 did not suppress inflammation. Treatment with EE or ERA-63 suppressed clinical signs in collagen induced arthritis (CIA) in WT mice. This was associated with reduced inflammatory infiltrates and decreased levels of proinflammatory cytokines in CIA joints.

Conclusions: ERalpha, but not ERbeta, is key in ER-mediated suppression of experimental arthritis. It remains to be investigated how these findings translate to human autoimmune disease.

Citing Articles

Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics.

Shepherd R, Cheung A, Pang K, Saffery R, Novakovic B Front Immunol. 2021; 11:604000.

PMID: 33584674 PMC: 7873844. DOI: 10.3389/fimmu.2020.604000.

Estradiol replacement therapy regulates innate immune response in ovariectomized arthritic mice.

Schneider A, Kanashiro A, Dutra S, de Souza R, Veras F, Cunha F Int Immunopharmacol. 2019; 72:504-510.

PMID: 31055232 PMC: 7023895. DOI: 10.1016/j.intimp.2019.04.048.

Estrogen receptor α in T cells suppresses follicular helper T cell responses and prevents autoimmunity.

Kim D, Park H, Park H, Lee J, Ko C, Gye M Exp Mol Med. 2019; 51(4):1-9.

PMID: 30988419 PMC: 6465332. DOI: 10.1038/s12276-019-0237-z.

Immune-Specific Expression and Estrogenic Regulation of the Four Estrogen Receptor Isoforms in Female Rainbow Trout (Oncorhynchus mykiss).

Casanova-Nakayama A, Wernicke von Siebenthal E, Kropf C, Oldenberg E, Segner H Int J Mol Sci. 2018; 19(4).

PMID: 29561790 PMC: 5979597. DOI: 10.3390/ijms19040932.

The effects of 17 alpha-estradiol to inhibit inflammation in vitro.

Santos R, de Fatima L, Frank A, Carneiro E, Clegg D Biol Sex Differ. 2017; 8(1):30.

PMID: 28877759 PMC: 5586055. DOI: 10.1186/s13293-017-0151-9.

References

Hall G, Daniels M, Huskisson E, Spector T . A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis. 1994; 53(2):112-6. PMC: 1005262. DOI: 10.1136/ard.53.2.112. View

Barrett J, Brennan P, Fiddler M, Silman A . Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum. 2000; 43(5):1010-5. DOI: 10.1002/1529-0131(200005)43:5<1010::AID-ANR8>3.0.CO;2-O. View

Carlsten H, Tarkowski A, Holmdahl R, Nilsson L . Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol. 1990; 80(3):467-73. PMC: 1535196. DOI: 10.1111/j.1365-2249.1990.tb03311.x. View

Jansson L, Olsson T, Holmdahl R . Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol. 1994; 53(2):203-7. DOI: 10.1016/0165-5728(94)90030-2. View

Haupl T, Ostensen M, Grutzkau A, Radbruch A, Burmester G, Villiger P . Reactivation of rheumatoid arthritis after pregnancy: increased phagocyte and recurring lymphocyte gene activity. Arthritis Rheum. 2008; 58(10):2981-92. DOI: 10.1002/art.23907. View

Mosselman S, Polman J, Dijkema R . ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996; 392(1):49-53. DOI: 10.1016/0014-5793(96)00782-x. View

DEMERS R, BLAIS J, Pretty H . [Rheumatoid arthritis treated by norethynodrel associated with mestranol: clinical aspects and laboratory tests]. Can Med Assoc J. 1966; 95(8):350-4. PMC: 1936653. View

Kuiper G, Gustafsson J . The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 1997; 410(1):87-90. DOI: 10.1016/s0014-5793(97)00413-4. View

Bijlsma J, Huber-Bruning O, Thijssen J . Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. Ann Rheum Dis. 1987; 46(10):777-9. PMC: 1003387. DOI: 10.1136/ard.46.10.777. View

10.

Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko M . Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum. 2008; 59(3):302-10. PMC: 2661110. DOI: 10.1002/art.23325. View

11.

Joosten L, Helsen M, Saxne T, van De Loo F, Heinegard D, van den Berg W . IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol. 1999; 163(9):5049-55. View

12.

Dulos J, Verbraak E, Bagchus W, Boots A, Kaptein A . Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta. Arthritis Rheum. 2004; 50(10):3346-53. DOI: 10.1002/art.20509. View

13.

Mehmood Z, Smith A, Tucker M, Chuzel F, Carmichael N . The development of methods for assessing the in vivo oestrogen-like effects of xenobiotics in CD-1 mice. Food Chem Toxicol. 2000; 38(6):493-501. DOI: 10.1016/s0278-6915(00)00022-3. View

14.

Sinkevicius K, Burdette J, Woloszyn K, Hewitt S, Hamilton K, Sugg S . An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology. 2008; 149(6):2970-9. PMC: 2408815. DOI: 10.1210/en.2007-1526. View

15.

Subramanian S, Matejuk A, Zamora A, Vandenbark A, Offner H . Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J Immunol. 2003; 170(3):1548-55. DOI: 10.4049/jimmunol.170.3.1548. View

16.

Phiel K, Henderson R, Adelman S, Elloso M . Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett. 2005; 97(1):107-13. DOI: 10.1016/j.imlet.2004.10.007. View

17.

Tiwari-Woodruff S, Morales L, Lee R, Voskuhl R . Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci U S A. 2007; 104(37):14813-8. PMC: 1976208. DOI: 10.1073/pnas.0703783104. View

18.

Langer G, Bader B, Meoli L, Isensee J, Delbeck M, Ruiz Noppinger P . A critical review of fundamental controversies in the field of GPR30 research. Steroids. 2009; 75(8-9):603-10. DOI: 10.1016/j.steroids.2009.12.006. View

19.

Harris H, Albert L, Leathurby Y, Malamas M, Mewshaw R, Miller C . Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology. 2003; 144(10):4241-9. DOI: 10.1210/en.2003-0550. View

20.

Green S, Walter P, Kumar V, Krust A, Bornert J, Argos P . Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986; 320(6058):134-9. DOI: 10.1038/320134a0. View